Targeted Therapies for Gastrointestinal Cancer

Targeted Therapies for Gastrointestinal Cancer

Friday, March 14, 2008

The New York Academy of Sciences

Presented By

Presented by the Mushett Family Foundation, the New York Academy of Sciences, and Memorial Sloan-Kettering Cancer Center

 

The New York Academy of Sciences is proud to present the inaugural Mushett Family Foundation symposium on colorectal cancer. Colorectal cancer is the third most common cancer world wide and the second leading cause of cancer-related deaths in the Western world. Early detection is essential for successful treatment of colorectal cancer; however current diagnostic tools and therapies are limited in their ability to detect these crucial early signs. The goal of this symposium is to bring together leading scientists and clinicians to discuss current advances in biomarker detection and targeted therapies, and to review recent and ongoing clinical trials. The meeting will conclude with an important panel to discuss ways to integrate new technologies in biomarker development into future clinical trials.

Scientific Organizing Committee

  • Joanna Groden, PhD, The Ohio State University
  • Christoph Lengauer, PhD, MBA, Novartis Institute for BioMedical Research
  • Martin Werner, MD, Albert-Ludwig University Freiburg, Germany
  • Kathy Granger, PhD, The New York Academy of Sciences


Course Director


David Klimstra, MD, Memorial Sloan-Kettering Cancer Center


    This program has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Memorial Sloan-Kettering Cancer Center and The New York Academy of Sciences. Memorial Sloan-Kettering Cancer Center is accredited by the ACCME to provide continuing medical education for physicians. Memorial Sloan-Kettering Cancer Center designates this educational activity for a maximum of 7 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This program has been planned and produced in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).